# To Assess Use of Vancomycin Powder in Craniotomy on Wound Infection Rates

> **NCT04917627** · PHASE4 · UNKNOWN · sponsor: **Hamad General Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Wound Infection

## Interventions

- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT04917627
- **Lead sponsor:** Hamad General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04917627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04917627, "To Assess Use of Vancomycin Powder in Craniotomy on Wound Infection Rates". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04917627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*